KIT and autoimmune thrombocytopenic purpura: While processing the validation of the KIT, we initiated a study on a different pediatric cohort which is the first prospective attempt to assess the well-being of children with ITP from diagnosis to six months with the generic PedsQLTM 4.0 Generic Core Scales.